The expected down scheduling of CBD to make it available in pharmacies will ultimately be a good thing for consumers, according to Elixinol CEO Oliver Horn.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Under an application outlined by the Therapeutic Goods Administration (TGA), low-dose CBD – defined as 60mg per day for a maximum of 30 days – will be downgraded to schedule 3 of the Poisons Standard, making it available without prescription from pharmacies.